Investor Readiness Command Center
Enterprise diligence snapshot for SCRIMED’s no-PHI healthcare intelligence platform.
SCRIMED is ready for synthetic demos, buyer diligence, platform audit review, and execution-attempt evidence binding while PHI, live clinical action, payer submission, patient outreach, EHR writeback, and certification claims remain blocked.
Safety posture
Buyer diligence is enabled; live clinical production remains blocked.
Investor Readiness Command Center is a no-PHI diligence and operating-readiness surface. It is not investment advice, securities material, audited financial reporting, compliance certification, clinical validation, live patient-care authority, PHI authority, customer go-live approval, or production connector approval.
clinical-robustness-lab-active-no-phi
Clinical Robustness Lab
Evidence route /api/clinical-robustness-lab; operating route /clinical-robustness-lab.
Review artifactexecution-attempt-envelope-active-no-phi
Execution Attempt Envelope
Evidence route /api/workflows/execution-attempts/envelope; operating route /workflows/execution-attempts.
Review artifactexecution-attempt-durable-store-contract-active-no-phi
Execution Attempt Durable Store
Evidence route /api/workflows/execution-attempts/durable-store; operating route /workflows/execution-attempts.
Review artifactaal2-smoke-readiness-preflight-ready-no-secret
AAL2 Smoke Readiness
Evidence route /api/qa-evidence/aal2-smoke-readiness; operating route /qa-aal2-run-evidence.
Review artifactrelease-evidence-ledger-active-no-secret
Release Evidence Ledger
Evidence route /api/release-continuity/evidence-ledger; operating route /release-continuity#release-evidence-ledger.
Review artifactrelease-evidence-promotion-queue-active-human-gated
Release Evidence Promotion Queue
Evidence route /api/release-continuity/evidence-promotion; operating route /release-continuity#release-evidence-promotion.
Review artifactrelease-evidence-freshness-guard-active-no-secret
Release Evidence Freshness Guard
Evidence route /api/release-continuity/evidence-freshness-guard; operating route /release-continuity#release-evidence-freshness-guard.
Review artifactrelease-authorization-chain-active-no-release-approval
Release Authorization Chain
Evidence route /api/release-continuity/authorization-chain; operating route /release-continuity#release-authorization-chain.
Review artifactdiligence-release-gate-active-no-production-approval
Diligence Release Gate
Evidence route /api/release-continuity/diligence-gate; operating route /release-continuity#diligence-release-gate.
Review artifactdiligence-packet-manifest-active-no-secret
Diligence Packet Manifest
Evidence route /api/release-continuity/diligence-packet-manifest; operating route /release-continuity#diligence-packet-manifest.
Review artifactdiligence-packet-share-guard-active-human-gated
Diligence Packet Share Guard
Evidence route /api/release-continuity/diligence-packet-share-guard; operating route /release-continuity#diligence-packet-share-guard.
Review artifactrecipient-qualification-matrix-active-no-secret
Recipient Qualification Matrix
Evidence route /api/release-continuity/recipient-qualification-matrix; operating route /release-continuity#recipient-qualification-matrix.
Review artifactenterprise-risk-register-active-no-phi
Enterprise Risk Register
Evidence route /api/risk-register; operating route /risk-register.
Review artifactscrimed-product-readiness-registry-active-no-phi
Product Readiness Registry
Evidence route /api/products/readiness; operating route /product.
Review artifactRelease authorization chain
Diligence evidence now resolves through a weakest-link control view.
SCRIMED Release Authorization Chain composes the no-secret release ledger, evidence freshness guard, diligence gate, packet manifest, recipient qualification matrix, share guard, and AAL2 readiness into one weakest-link control view. It does not approve release, share packets, store recipient identifiers, retain token material, authorize PHI, certify security or compliance, approve customer go-live, or authorize live clinical care.
blocked-by-design
no-secret-metadata-chain-not-release-approval
diligence-release-gate:blocked-by-design
Release evidence cannot become approval authority unless all required human and external reviews are complete.
release-authorization-831a9179
No token values, PHI, raw logs, recipient identifiers, or customer payloads are captured.
available-after-release-steward-review
Metadata may support diligence only after release steward review.
Deployment release checklist
Every buyer-facing release keeps public smoke, no-secret AAL2 readiness, and protected strict smoke separated.
required-before-release
Public production smoke
Public smoke remains the no-secret availability and fail-closed boundary check for buyer-facing deployments.
npm run smoke:public
- Route: /api/release-continuity
- Human review required: no
aal2-smoke-readiness-preflight-ready-no-secret
AAL2 smoke readiness preflight
No-secret readiness API exposes strict-smoke gates, safe commands, and fail-closed modes without token material.
npm run smoke:aal2:readiness
- Route: /api/qa-evidence/aal2-smoke-readiness
- Human review required: yes
blocked-until-human-aal2-and-feature-flag
Strict AAL2 durable-store smoke
Authenticated durable-store record, replay, and review disposition proof remains blocked until a fresh authorized AAL2 operator token and target feature flag exist.
npm run smoke:aal2:durable-store:strict
- Route: /api/workflows/execution-attempts/durable-store
- Human review required: yes
blocked-until-human-aal2
Stored-vector RPC strict smoke
Stored-vector lookup proof remains protected by the same short-lived AAL2 operator boundary.
npm run smoke:scrimed-stored-vector-rpc:strict
- Route: /api/scrimed-build-roadmap/stored-vector-rpc-smoke
- Human review required: yes
AAL2 smoke readiness
Strict protected proof remains human-gated, even when the public readiness packet is buyer-visible.
api/api/qa-evidence/aal2-smoke-readiness
brief/api/qa-evidence/aal2-smoke-readiness/brief
tokenshort-lived human token required
flagtarget feature flag required
Release evidence ledger
No-secret build, smoke, and readiness evidence is tracked separately from approvals.
SCRIMED Release Evidence Ledger records no-secret build, smoke, readiness, and protected-operator evidence metadata only. It does not store PHI, patient identifiers, bearer tokens, Supabase secrets, service-role keys, raw logs, production connector payloads, customer data, certification proof, release approval, or live clinical authority.
api/api/release-continuity/evidence-ledger
brief/api/release-continuity/evidence-ledger/brief
operator2
approvalnot approved
Release evidence promotion
Evidence is split into shareable metadata, operator proof blockers, and qualified-review blockers.
SCRIMED Release Evidence Promotion Queue converts no-secret release ledger entries into buyer-diligence candidates, protected operator proof blockers, and qualified-review requirements. It does not store PHI, tokens, raw logs, customer data, production connector payloads, certification evidence, public release approval, or live clinical authority.
api/api/release-continuity/evidence-promotion
buyerprotected-buyer-diligence-only-after-review
AAL2 proof2
public claimsnot-authorized-public-claim
Release evidence freshness
Buyer and investor evidence reuse requires a fresh rerun, AAL2 refresh, or qualified review when scope changes.
SCRIMED Release Evidence Freshness Guard is a no-secret recency and revalidation policy for release evidence. It does not rerun commands, store logs, store PHI, capture tokens, certify evidence, approve public distribution, approve production release, approve customer go-live, or authorize live clinical care.
api/api/release-continuity/evidence-freshness-guard
authorityfresh-rerun-required-before-external-use
refresh5
review1
Diligence release gate
Buyer diligence is GO only for no-secret metadata; production, public distribution, PHI, and clinical authority remain blocked.
SCRIMED Diligence Release Gate summarizes no-secret buyer diligence readiness while preserving NO-GO boundaries for protected AAL2 proof, public distribution, production release, PHI processing, certification, and live clinical care.
buyergo-no-secret-metadata-with-release-steward-review
AAL2no-go-until-human-aal2-retained-packet
publicno-go-until-qualified-review
clinicalno-go-not-authorized-live-care
Diligence packet manifest
Buyer and investor packets stay no-secret, review-owned, and explicit about withheld material.
SCRIMED Diligence Packet Manifest assembles no-secret buyer and investor diligence metadata only. It does not store PHI, bearer tokens, Supabase secrets, service-role keys, raw logs, customer data, production connector payloads, certification proof, release approval, public distribution approval, or live clinical authority.
hashdiligence-manifest-73403733
packetno-secret-buyer-investor-diligence-only
publicnot-authorized
items12
Diligence packet share guard
Packet sharing remains recipient-scoped, human-reviewed, and blocked from public distribution.
SCRIMED Diligence Packet Share Guard is a no-secret recipient and distribution control. It does not share packets, send emails, create calendar invites, approve public distribution, authorize PHI, certify security or compliance, approve production release, approve customer go-live, or authorize live clinical care.
hashdiligence-share-75b52bf1
externalprotected-diligence-only-after-human-review
recipientrecipient-specific-human-approval-required
publicnot-authorized
Recipient qualification matrix
External packet references now require recipient-class preflight, expiry, revocation, and no-identifier storage.
SCRIMED Recipient Qualification Matrix is a no-secret recipient policy preflight for diligence packet sharing. It does not store recipient names, recipient emails, access grants, raw access logs, bearer tokens, PHI, customer data, signed approvals, legal opinions, certification evidence, production connector payloads, public distribution approval, customer go-live approval, or live clinical care authorization.
hashrecipient-qualification-e13fcd32
recipient IDsnot-stored-in-scrimed
externalqualified-recipient-review-required
revocation6
synthetic-fallback-active-provider-calls-disabled-by-default
Provider adapters: 8; external calls enabled: false.
scrimed-cost-api-guardrails-v2026-06-29
Fail-closed verified: true; provider calls enabled: false.
synthetic-and-metadata-only
FHIR/HL7/DICOM/X12 architecture review, buyer diligence, and no-PHI connector planning.
NO-GO boundaries
Preserved before clinical production.
- Live PHI/ePHI, patient identifiers, source charts, production credentials, or live records.
- Autonomous or final diagnosis, triage replacement, or clinical decision authority.
- Autonomous treatment plans, patient-specific care instructions, or therapy selection.
- Medication prescribing, medication changes, order placement, or pharmacy actions.
- Patient texting, calling, emailing, portal messaging, or outreach automation.
- Claims submission, prior authorization submission, appeal filing, or reimbursement assurance.
- EHR writeback, chart filing, record mutation, order entry, or connector writes.
- Production EHR, payer, device, imaging, or third-party connector activation approval.
- HIPAA, SOC 2, HITRUST, FDA, ONC, clinical validation, security, or accessibility certification claims.
Next milestones
Highest-leverage path toward enterprise deployment.
- Run /api/release-continuity/authorization-chain before any external packet reference so the weakest-link state is visible across evidence, freshness, manifest, recipient, share, and AAL2 controls.
- Run /api/release-continuity/evidence-freshness-guard before evidence is reused in buyer, investor, clinical, security, public, or customer-specific contexts.
- Use /api/release-continuity/recipient-qualification-matrix before external packet references so recipient class, expiry, revocation, and no-identifier storage are explicit.
- Use /api/release-continuity/diligence-packet-share-guard before buyer, investor, public, customer-specific, clinical, or security packet references leave SCRIMED.
- Use /api/release-continuity/diligence-packet-manifest to assemble buyer and investor packets from allowed no-secret fields while withholding AAL2 proof, public claims, certification claims, PHI, and clinical authority.
- Use the Diligence Release Gate to present no-secret buyer-diligence GO items separately from AAL2, public-distribution, production, and clinical NO-GO items.
- Use the Release Evidence Promotion Queue to separate shareable metadata, operator proof blockers, and qualified-review blockers before buyer distribution.
- Promote AAL2 smoke readiness and strict-smoke outcomes into protected buyer workspaces with tenant RBAC.
- Add OAuth scoped-token MCP gateway with revocation and tool-level authorization.
- Add reviewer-calibrated evaluation datasets and release-blocking regression checks.
- Prepare legal, privacy, security, and clinical governance packets before any PHI or production connector approval.